Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434
Alterity Therapeutics Limited (NASDAQ:ATHE) is one of the best performing ASX stocks in 2025.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 22,144 | $83,483 | 0% | |
| 2. | Point72 Asset Management Steve Cohen | 0 | $0 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 58,460 | $180,057 | 0% | |
| 2. | 32,000 | $98,560 | 0% | |
| 3. | 790 | $2,433 | 0% | |
| 4. | 40 | $123 | 0% | |
| 5. | 22 | $68 | 0% |